Armata Pharmaceuticals (ARMP) Tax Provisions (2015 - 2017)
Armata Pharmaceuticals' (ARMP) quarterly Tax Provisions came in at -$1.3 million in Q2 2017, down 1683.56% quarter-over-quarter from -$73000.0 in Q4 2015.
Armata Pharmaceuticals (ARMP) Tax Provisions (2015 - 2017) Analysis & Trends
Armata Pharmaceuticals has disclosed Tax Provisions across 2 years of filings, most recently posting -$1.3 million for Q2 2017.
- Tax Provisions for Q2 2017 came in at -$1.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was -$1.4 million (changed N/A YoY), and the FY2018 annual result was -$328000.0, up 74.81% from the prior year.
- Tax Provisions came in at -$1.3 million for Q2 2017 at Armata Pharmaceuticals, down from -$73000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of -$73000.0 in Q4 2015 to a low of -$1.3 million in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -1.30 Mn |
| Dec 31, 2015 | -73,000.00 |